York Exports (530675)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹38.15 |
| Market Cap | ₹13.09 Cr |
| P/E Ratio | 3.81 |
| ROCE | 17% |
| ROE | 7.11% |
| Dividend Yield | 0% |
| Profit Growth | -81.42% |
| Debt/Equity | — |
| Sales Growth | 30.46% |
| 52-Week Range | ₹49.6 — ₹79 |
| Sector | Consumer Durables |
| Book Value | ₹33.85 |
Strengths
- Price close to book value: P/B 1.13 with book value ₹33.85 against price ₹38.15
- Trailing P/E of 3.81 is statistically cheap if current earnings hold
- Sales growth of 30.46% shows top-line momentum
- Latest quarter is profitable: ₹15 Cr sales and ₹1 Cr net profit
- ROCE of 17% suggests decent operational capital efficiency
Concerns
- Profit growth collapsed -81.42% despite 30.46% sales growth, indicating severe margin pressure
- Piotroski F-Score of 4/9 points to weak financial health
- No dividend means total return depends entirely on uncertain capital appreciation
- Promoter holding and debt/equity are N/A, and price is below the stated 52-week range, raising transparency and data integrity concerns
AI Analysis
At first glance, York Exports looks like a classic Graham 'cigar butt'. The price of ₹38.15 is barely above the book value of ₹33.85, so the P/B is only 1.13, and the trailing P/E is 3.81. A ₹13 crore market cap means this is a microcap, so liquidity and information quality matter. But cheapness is not enough. Return on equity is just 7.11%, and while ROCE is 17%, the profit picture is disturbing: sales grew 30.46% but profit fell 81.42%. That gap tells me revenue is coming without earnings quality. The latest quarter, sales of ₹15 crore produced only ₹1 crore profit; if that annualises to roughly ₹4 crore, the P/E is low, but margins could easily be squeezed in this cyclical jewellery business. There is no dividend, so the small shareholder must rely entirely on capital appreciation. The Piotroski F-score of 4/9 is another warning: financial health is below average. Promoter holding and debt/equity are not disclosed, so I cannot assess skin in the game or leverage. Worse, the stock trades below the stated 52-week range of ₹49.60–₹79.00; that may be a data error, but if real, it suggests distress. In Buffett's language, this is not a wonderful business. Gems and jewellery is capital-intensive, competitive, and subject to changing tastes and gold price cycles; I see no durable moat. The asset base supports the price, but not enough margin of safety to call it a high-conviction investment. I would only consider it as a speculative cyclical watch, and I would demand proof that the profit decline is reversing before putting money at risk.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer